Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.
now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now


Latest news

November 22, 2021
The European Commission has approved SKYRIZI® for the treatment of active psoriatic arthritis in adults.
November 18, 2021
The European Academy of Dermatology and Venerelogy 30th Annual Congress (EADV) was packed with science and clinical practice updates. You can download the full report or read a brief look at some of the highlights.
November 04, 2021
PsoProtect, a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data and now includes the first 1,272 cases.
November 02, 2021
The European Medicines Agency (EMA) has accepted to review Boehringer Ingelheim’s marketing authorization application (MAA) for spesolimab to treat flares in generalised pustular psoriasis (GPP).
More News

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK